Enfermedades cerebrovasculares (ECV)

MUNOZ-COLLAZOS M, MORILLO LE, ARANGO GJ, BAYONA H, CELIS J, GÓMEZ G, RAMÍREZ S, RESTREPO J, SILVA F, URIBE M, USTA E, VARELA GP, ZUNIGA G. Latin American Stroke Registry (LARS) Colombian Branch: one year report. Cerebrovasc Dis. 2010; 29(suppl2): 217.

National Center for Health Statistics. Prevalence of overweight and obesity among adults: United States, 1999. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/obese/obse99table2.htm.

DAPHNE P GU, WEI ZHANG, BANSBACK N, AMARSI Z, BIRMINGHAM L, ANIS AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009, 9:88.

ABOTT RD, BEHRENS GR, SHARP DS, RODRIGUEZ BL, BURCHIFIEL CM, ROSS W, YANO K, CURB JD. Body mass index and thromboembolic stroke in nonsmoking men in older middle age: the Honolulu Heart Program. Stroke 1994;25:2370-2376.

HUBERT HB, FEINLEIB M, MCNAMARA PM, CASTELLI WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67: 968-977.

WALKER SP, RIMM EB, ASCHERIO A, KAWACHI I, STAMPFER MJ, WILLETT WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996;144:1143-1150.

DIENER HC, BOGOUSSLAVSKY J, BRASS LM, CIMMINIELLO C, CSIBA L, KASTE M, LEYS D, MATIAS-GUIU J, RUPPRECHT HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubleblind, placebo-controlled trial. Lancet 2004;364:331-337.

YATSUYA H, FOLSOM AR, YAMAGISHI K, NORTH KE, BRANCATI FL, STEVENS J, FOR THE ARIC STUDY INVESTIGATORS. Race- and Sex-Specific Associations of Obesity Measures With Ischemic Stroke Incidence in the Atherosclerosis Risk in Communities (ARIC) Study Stroke 2010;41:00-00.

STRAZZULLO P, D'ELIA L, CAIRELLA G, GARBAGNATI F. CAPPUCCIO FP, SCALFI L. Excess Body Weight and Incidence of Stroke Meta-Analysis of Prospective Studies With 2 Million Participants. Stroke. 2010;41:e418-e426.

MUÑOZ-COLLAZOS M, GUTIÉRREZ AM, LONDOÑO D, BAYONA H, HERRÁN S, PÉREZ GE. Uso del Activador de Plasminógeno Tisular Recombinante (rt-PA) en el Ataque Cerebrovascular isquémico (ACVi) en Colombia: un estudio de costo-efectividad Acta Neurol Colomb 2008;24:158-173.